This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Kalila Medical Announces Issuance Of Key Patent For TruVector™ Technology For Steerable Introducer Sheaths

CAMPBELL, Calif., April 2, 2013 /PRNewswire/ -- Kalila Medical, a privately held medical device company focused on the development of next-generation steerable catheter technologies, today announced the issuance of U.S. Patent No. 8,323,241 by the US Patent and Trademark Office (USPTO), titled "Steerable Medical Delivery Devices and Methods of Use". The company's proprietary technology encompasses a novel catheter tip deflection system that offers the superior precision and control required for increasingly complex electrophysiology and endovascular procedures. Kalila is the exclusive licensee of the patent, which has been issued to its affiliate Shifamed, LLC.

"This patent is central to our truVector™ technology, which enables tip deflection of catheter systems without the use of traditional pull-wires," said Mike Dineen, President and CEO of Kalila Medical. "Pull-wire based catheter deflection systems have inherent limitations including poor torque response and 'whipping' of the catheter tip during rotation. The truVector™ technology solution is a first-of-its-kind coaxial system that substantially improves the performance of products such as steerable introducer sheaths." 

"During an RF ablation procedure, precise and predictable torque response and tip positioning are crucial for a successful treatment; millimeter shifts can affect procedural outcomes," states Dr. Girish Narayan, an electrophysiologist from Palo Alto Medical Foundation in Palo Alto, California. "The truVector™ technology has the potential to offer control currently not available with other steerable sheaths."

The Vado™ Steerable Sheath is Kalila Medical's first product to utilize the proprietary truVector™ technology. Currently in the final stages of development, the Vado sheath is expected to be submitted for regulatory approval in the second half of 2013. 

About Kalila MedicalFounded in 2010, Kalila Medical is a privately held medical device company, formed by Shifamed LLC, a Silicon Valley based medical device incubator. Kalila's first product, the Vado TM Steerable Sheath, is redefining precision and control with an innovative platform of specialized delivery and access catheters. The procedural benefits of Kalila's proprietary truVector™ technology can be leveraged across a growing number of endovascular applications including atrial fibrillation ablation, mitral valve repair, ASD/PFO closure, left atrial appendage closure, transseptal puncture, and LV lead placement.

For more information please visit www.kalilamedical.com.

MEDIA CONTACT: Katie ArnoldSPRIG Consulting LLC(408) 805-0520 katie@sprigconsulting.com

SOURCE Kalila Medical

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs